Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04373265
Title Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Corcept Therapeutics
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.